Veracyte | VCYT - Current Assets


Veracyte reported $449.22M in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
Agilent USD 4.59B 341M Sep/2025
Arrowhead Research USD 950.64M 3.72M Sep/2025
Bruker USD 2.35B 187.9M Sep/2025
Exact Sciences USD 1.59B 82.87M Sep/2025
Illumina USD 2.8B 155M Sep/2025
Laboratory Of America USD 4.08B 8.4M Sep/2025
Ligand Pharmaceuticals USD 753.92M 400.98M Sep/2025
Myriad Genetics USD 344.8M 60.5M Sep/2025
Roche Holding CHF 38.73B 3.03B Dec/2025
Siemens EUR 64.71B 1.08B Sep/2025
Sonic Healthcare AUD 2.3B 52.76M Dec/2024
Thermo Fisher Scientific USD 28.71B 6.41B Dec/2025
Veracyte USD 449.22M 34.54M Sep/2025
Waters USD 1.92B 137.07M Sep/2025